XML 46 R36.htm IDEA: XBRL DOCUMENT v3.19.2
Basis of Presentation, Liquidity and Summary of Significant Accounting Policies (Details Narrative) - USD ($)
$ / shares in Units, $ in Thousands
1 Months Ended 3 Months Ended 6 Months Ended
Jan. 02, 2019
Jul. 31, 2019
Mar. 31, 2019
Jun. 30, 2018
Mar. 31, 2018
Jun. 30, 2019
Aug. 06, 2019
Mar. 08, 2019
Dec. 31, 2018
Dec. 31, 2017
Proceeds from sale of equity                  
Accumulated deficit           (252,435)     $ (261,856)  
Working capital           12,600        
Shareholders' equity     $ 161,236 $ 104,751 $ 102,455 131,759     $ 92,246 $ 164,263
Cash and cash equivalents and marketable securities           16,700        
Common stock closing price per share               $ 1.31 $ 0.62  
Common stock, value           $ 385,615     $ 354,270  
Debt instrument maturity date           Aug. 30, 2020        
Lease payment rate, description           For lease classification determination, BioTime continues to use (i) greater to or equal to 75% to determine whether the lease term is a major part of the remaining economic life of the underlying asset and (ii) greater to or equal to 90% to determine whether the present value of the sum of lease payments is substantially the fair value of the underlying asset.        
Value of leasehold improvements $ 1,900                  
Operating lease liabilities 2,000         $ 4,748        
Cumulative effect adjustment $ 100   $ 143 $ 1 $ 101          
OncoCyte Corporation [Member]                    
Equity investments           $ 36,539     $ 20,250  
Common stock closing price per share     $ 3.95 $ 2.55 $ 2.10 $ 2.49     $ 1.38 $ 4.65
Subsequent Event [Member] | OncoCyte Corporation [Member]                    
Equity investments             $ 21,700      
Common stock closing price per share             $ 1.75      
Subsequent Event [Member] | OncoCyte [Member]                    
Proceeds from sale of equity   $ 4,200                
Subsequent Event [Member] | Hadasit [Member]                    
Proceeds from sale of equity   $ 1,200